Follow us on:

Linkedin Facebook

Bridgepoint Group PLC 36.1% potential upside indicated by JP Morgan

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Bridgepoint Group PLC with ticker (LON:BPT) now has a potential upside of 36.1% according to JP Morgan.



JP Morgan set a target price of 570 GBX for the company, which when compared to the Bridgepoint Group PLC share price of 365 GBX at opening today (28/01/2022) indicates a potential upside of 36.1%. Trading has ranged between 359 (52 week low) and 571 (52 week high) with an average of 985,601 shares exchanging hands daily. The market capitalisation at the time of writing is £2,984,349,400.

Bridgepoint Group plc, formerly Bridgepoint Group Limited, is a private equity firm. Moelis & Company UK LLP is the financial adviser to the Company.



Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Broker Ratings

    Bridgepoint Group PLC 19.2% potential upside indicated by JP Morgan

    Broker Ratings

    Bridgepoint Group PLC 20.2% potential upside indicated by Jefferies

    Broker Ratings

    Bridgepoint Group PLC 20.2% potential upside indicated by Jefferies

    Broker Ratings

    Bridgepoint Group PLC -2.6% potential downside indicated by JP Morgan Cazenove

    Broker Ratings

    Bridgepoint Group PLC 5.4% potential upside indicated by JP Morgan Cazenove

    Broker Ratings

    Bridgepoint Group PLC 20.4% potential upside indicated by Bank of America

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.